Clinical Trial: A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958692) titled 'A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder' on March 30.

Brief Summary: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial, aim to evaluate the efficacy and safety of dextromethorphan and bupropion sustained-release tablets in Chinese adult patients with major depressive disorder.

Study Start Date: April 11

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD)

Intervention: DRUG: Dextromethorphan and Bupropion Sustained-Release Tablets

Oral dextromethorphan and bupropion sustained-release tablets, taken daily for 6 weeks....